Vaccine-Acquired SARS-CoV-2 Immunity versus Infection-Acquired Immunity: A Comparison of Three COVID-19 Vaccines
Around the world, rollout of COVID-19 vaccines has been used as a strategy to end COVID-19-related restrictions and the pandemic. Several COVID-19 vaccine platforms have successfully protected against severe SARS-CoV-2 infection and subsequent deaths. Here, we compared humoral and cellular immunity...
Main Authors: | Marie I. Samanovic, Aaron L. Oom, Amber R. Cornelius, Sophie L. Gray-Gaillard, Trishala Karmacharya, Michael Tuen, Jimmy P. Wilson, Meron F. Tasissa, Shelby Goins, Ramin Sedaghat Herati, Mark J. Mulligan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/10/12/2152 |
Similar Items
-
The SARS-CoV-2 Variant Omicron Is Able to Escape Vaccine-Induced Humoral Immune Responses, but Is Counteracted by Booster Vaccination
by: Florian D. Hastert, et al.
Published: (2022-05-01) -
The SARS-CoV-2 Delta-Omicron Recombinant Lineage (XD) Exhibits Immune-Escape Properties Similar to the Omicron (BA.1) Variant
by: Prerna Arora, et al.
Published: (2022-11-01) -
Neutralization Effect of Sera against Delta and Omicron in Patients Recovering from COVID-19 and Inactivated Vaccine Recipients
by: Yajuan Zhu, et al.
Published: (2023-02-01) -
Cellular Immunity—The Key to Long-Term Protection in Individuals Recovered from SARS-CoV-2 and after Vaccination
by: Dragan Primorac, et al.
Published: (2022-03-01) -
Effectiveness of COVID-19 Vaccine Booster Shot Compared with Non-Booster: A Meta-Analysis
by: Yajuan Zhu, et al.
Published: (2022-08-01)